Skip to main content
Top
Published in: Abdominal Radiology 11/2020

01-11-2020 | Computed Tomography | Kidneys, Ureters, Bladder, Retroperitoneum

Using texture analysis as a predictive factor of subtype, grade and stage of renal cell carcinoma

Authors: Servan Yaşar, Nuray Voyvoda, Bekir Voyvoda, Tülay Özer

Published in: Abdominal Radiology | Issue 11/2020

Login to get access

Abstract

Objective

The aim of this study was to evaluate the correlation between the tissue texture analysis and the histological subtypes, grade and stage of the disease in patients with renal cell carcinoma (RCC).

Materials and methods

Seventy-seven patients who underwent computed tomography due to renal mass and diagnosed with RCC as a result of pathological examination were retrospectively analyzed. In these analyses, the demographic characteristics, pathological and radiological findings of the patients were evaluated. The masses were introduced to the Radiomics extension of the software and the first- and second-order texture analysis parameters were obtained. The correlation of these parameters with histological subtype, Fuhrman grade and TNM stage was investigated.

Results

In the comparison of the Radiomics values by stages, “minimum”, “Long Run Low Gray-level Emphasis” values were higher in the stage 1–2 group, while “Energy”, “Total energy”, “Range”, “Joint Average”, “Sum Average”, “Gray-Level Non-Uniformity”, “Short-Run High Gray-level Emphasis “, “Run Length Non-Uniformity “and “High Gray-Level Run Emphasis “values were higher in the stage 3–4 group. Of these parameters, only “Gray-Level Non-Uniformity” and “Run Length Non-Uniformity’’ values were significantly lower in tumors with low Fuhrman grade (1–2) and low TNM stage (1–2). There was no statistically significant correlation between the parameters found to be significant in histological subtype differentiation and Fuhrman grade and TNM stage.

Conclusion

This study demonstrates that “Gray-Level Non-Uniformity” and “Run Length Non-Uniformity “parameters in the texture analysis method can be used to evaluate the prognosis in patients with RCC.
Literature
1.
go back to reference Göğüs C, Baltacı S, Filiz E, Elhan A, Beduk Y. (2004) Significance of thrombocytosis for determining prognosis in patients with lokalized renal cell carsinoma. Urology 63: 447-450.CrossRef Göğüs C, Baltacı S, Filiz E, Elhan A, Beduk Y. (2004) Significance of thrombocytosis for determining prognosis in patients with lokalized renal cell carsinoma. Urology 63: 447-450.CrossRef
2.
go back to reference Landis SH, Murray T, Bolden S et al. (1999) Cancer statistics. CA Cancer J. Clin. 49: 8.CrossRef Landis SH, Murray T, Bolden S et al. (1999) Cancer statistics. CA Cancer J. Clin. 49: 8.CrossRef
3.
go back to reference Johnsen JA, Hellsten S. (1997) Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol. 157:450-3.CrossRef Johnsen JA, Hellsten S. (1997) Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol. 157:450-3.CrossRef
4.
go back to reference Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, Ma ZL, Liu ZY (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer, J. Clin. Oncol. 34 (18) 2157–2164.CrossRef Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, Ma ZL, Liu ZY (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer, J. Clin. Oncol. 34 (18) 2157–2164.CrossRef
5.
go back to reference Birkhahn M, Mitra AP, Cote RJ (2007) Molecular markers for bladder cancer: the road to a multimarker approach, Expert Rev. Anticancer Ther. 7 (12) 1717–1727.CrossRef Birkhahn M, Mitra AP, Cote RJ (2007) Molecular markers for bladder cancer: the road to a multimarker approach, Expert Rev. Anticancer Ther. 7 (12) 1717–1727.CrossRef
6.
go back to reference Croner RS, Fortsch T, Bruckl WM, Rodel F, Rodel C, Papadopoulos T, Brabletz T, Kirchner T, Sachs M, Behrens J, L. Klein-Hitpass, M. Sturzl,W. Hohenberger,B.Lausen, (2008) Molecular signature for lymphatic metastasis in colorectal carcinomas, Ann. Surg. 247 (5) :803–810.CrossRef Croner RS, Fortsch T, Bruckl WM, Rodel F, Rodel C, Papadopoulos T, Brabletz T, Kirchner T, Sachs M, Behrens J, L. Klein-Hitpass, M. Sturzl,W. Hohenberger,B.Lausen, (2008) Molecular signature for lymphatic metastasis in colorectal carcinomas, Ann. Surg. 247 (5) :803–810.CrossRef
7.
go back to reference Ficarra V, Galfano A, Novara G, et al. (2008) Risk stratification and prognostication of renal cell carsinoma. World J Urol. 26: 115-125.CrossRef Ficarra V, Galfano A, Novara G, et al. (2008) Risk stratification and prognostication of renal cell carsinoma. World J Urol. 26: 115-125.CrossRef
8.
go back to reference Sheir KZ, El-Azab M, Mosbah A, et al. (2005) Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol. 174:451–455.CrossRef Sheir KZ, El-Azab M, Mosbah A, et al. (2005) Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol. 174:451–455.CrossRef
9.
go back to reference Kim JH, Bae JH, Lee KW, et al. (2012) Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging. Urology. 80:872–876.CrossRef Kim JH, Bae JH, Lee KW, et al. (2012) Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging. Urology. 80:872–876.CrossRef
10.
go back to reference Jung SC, Cho JY, Kim SH. (2012) Subtype differentiation of small renal cell carcinomas on three-phase MDCT: usefulness of the measurement of degree and heterogeneity of enhancement. Acta Radiol. 53:112–118. [PubMed: 22114020]CrossRef Jung SC, Cho JY, Kim SH. (2012) Subtype differentiation of small renal cell carcinomas on three-phase MDCT: usefulness of the measurement of degree and heterogeneity of enhancement. Acta Radiol. 53:112–118. [PubMed: 22114020]CrossRef
11.
go back to reference Zhang J, Lefkowitz R, Ishill N, et al. (2007) Solid renal cortical tumors: differentiation with CT. Radiology. 244:494–504CrossRef Zhang J, Lefkowitz R, Ishill N, et al. (2007) Solid renal cortical tumors: differentiation with CT. Radiology. 244:494–504CrossRef
12.
go back to reference Choi SK, Jeon SH, Chang SG. (2012) Characterization of small renal masses less than 4 cm with quadriphasic multidetector helical computed tomography: differentiation of benign and malignant lesions. Korean J Urol. 53:159–164.CrossRef Choi SK, Jeon SH, Chang SG. (2012) Characterization of small renal masses less than 4 cm with quadriphasic multidetector helical computed tomography: differentiation of benign and malignant lesions. Korean J Urol. 53:159–164.CrossRef
13.
go back to reference Jinzaki M, Tanimoto A, Mukai M, et al. (2000) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr. 24:835–842.CrossRef Jinzaki M, Tanimoto A, Mukai M, et al. (2000) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr. 24:835–842.CrossRef
14.
go back to reference Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinom subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 267:444–453.CrossRef Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinom subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 267:444–453.CrossRef
15.
go back to reference Herts B, Coll D, Novick A, et al. (2002) Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol. 178:367–37CrossRef Herts B, Coll D, Novick A, et al. (2002) Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol. 178:367–37CrossRef
16.
go back to reference Bird VG, Kanagarajah P, Morillo G, et al. (2011) Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography. World J Urol. 29:787–792.CrossRef Bird VG, Kanagarajah P, Morillo G, et al. (2011) Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography. World J Urol. 29:787–792.CrossRef
17.
go back to reference Raman SP, Johnson PT, Allaf ME, et al. (2013) Chromophobe renal cell carcinoma: multiphase MDCT enhancement patterns and morphologic features. AJR Am J Roentgenol. 201:1268–1276.CrossRef Raman SP, Johnson PT, Allaf ME, et al. (2013) Chromophobe renal cell carcinoma: multiphase MDCT enhancement patterns and morphologic features. AJR Am J Roentgenol. 201:1268–1276.CrossRef
18.
go back to reference Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577.CrossRef Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577.CrossRef
19.
go back to reference Lambin P, Leijenaar RTH, Deist T et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762.CrossRef Lambin P, Leijenaar RTH, Deist T et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762.CrossRef
20.
go back to reference Lubner MG, et al. (2016) CT textural analysis of large primary renal cell carcinomas: pretreatment tumor heterogeneity correlates with histologic findings and clinical outcomes. AJR Am J Roentgenol 207(1):96–105.CrossRef Lubner MG, et al. (2016) CT textural analysis of large primary renal cell carcinomas: pretreatment tumor heterogeneity correlates with histologic findings and clinical outcomes. AJR Am J Roentgenol 207(1):96–105.CrossRef
21.
go back to reference Kumar, Gu V, Basu Y, Berglund S, Eschrich A, Schabath SA (2012). Radiomics: the process and the challenges. Magnetic Resonance Imaging, 30(9), 1234–1248.CrossRef Kumar, Gu V, Basu Y, Berglund S, Eschrich A, Schabath SA (2012). Radiomics: the process and the challenges. Magnetic Resonance Imaging, 30(9), 1234–1248.CrossRef
22.
go back to reference Ba-Ssalamah A, Muin D, Schernthaner R, et al. (2013) Texture-based classification of different gastric tumors at contrast-enhanced CT. Eur J Radiol. 82:e537–e543.CrossRef Ba-Ssalamah A, Muin D, Schernthaner R, et al. (2013) Texture-based classification of different gastric tumors at contrast-enhanced CT. Eur J Radiol. 82:e537–e543.CrossRef
23.
go back to reference Burke HB, Henson DE (1993) Criteria for prognostic factorsand for an enhanced prognostic system. Cancer, 72: 3131-3135,CrossRef Burke HB, Henson DE (1993) Criteria for prognostic factorsand for an enhanced prognostic system. Cancer, 72: 3131-3135,CrossRef
24.
go back to reference López JI, Angulo JC (2018). Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma. Current Urology Reports, 19(1). López JI, Angulo JC (2018). Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma. Current Urology Reports, 19(1).
25.
go back to reference Scrima AT, Lubner MG, Abel EJ, Havighurst TC, Shapiro DD, Huang W, Pickhardt PJ (2018) Texture analysis of small renal cell carcinomas at MDCT for predicting relevant histologic and protein biomarkers Scrima AT, Lubner MG, Abel EJ, Havighurst TC, Shapiro DD, Huang W, Pickhardt PJ (2018) Texture analysis of small renal cell carcinomas at MDCT for predicting relevant histologic and protein biomarkers
26.
go back to reference Novara G, Martignoni G, Artibani W, Ficarra V (2007) Grading systems in renal cell carcinoma, J. Urol. 177 (2) (430–436. Novara G, Martignoni G, Artibani W, Ficarra V (2007) Grading systems in renal cell carcinoma, J. Urol. 177 (2) (430–436.
27.
go back to reference Guethmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B, Swedish G (2011) Kidney Cancer Quality Register, Metastatic potential in renal cell carcinomas </=7 cm: Swedish Kidney Cancer Quality Register data, Eur. Urol. 60 (5): 975 982. Guethmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B, Swedish G (2011) Kidney Cancer Quality Register, Metastatic potential in renal cell carcinomas </=7 cm: Swedish Kidney Cancer Quality Register data, Eur. Urol. 60 (5): 975 982.
28.
go back to reference Ding J, Xing Z, Jiang Z, Chen J, Pan L, Qiu J, Xing W (2018). CT-based radiomic model predicts high grade of clear cell renal cell carcinoma. European Journal of Radiology, 103, 51–56.CrossRef Ding J, Xing Z, Jiang Z, Chen J, Pan L, Qiu J, Xing W (2018). CT-based radiomic model predicts high grade of clear cell renal cell carcinoma. European Journal of Radiology, 103, 51–56.CrossRef
29.
go back to reference Oh S, Sung DJ, Yang KS, Sim KC, Han NY, Park BJ, Kim MJ, Cho SB (2017) Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma, Acta Radiol. 58 (3): 376–384.CrossRef Oh S, Sung DJ, Yang KS, Sim KC, Han NY, Park BJ, Kim MJ, Cho SB (2017) Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma, Acta Radiol. 58 (3): 376–384.CrossRef
30.
go back to reference Hotker AM, Karlo CA, Zheng J, Moskowitz CS, Russo P, Hricak H, Akin O (2016) Clear cell renal cell carcinoma: associations between CT features and patient survival, AJR Am. J. Roentgenol. 206 (5): 1023–1030.CrossRef Hotker AM, Karlo CA, Zheng J, Moskowitz CS, Russo P, Hricak H, Akin O (2016) Clear cell renal cell carcinoma: associations between CT features and patient survival, AJR Am. J. Roentgenol. 206 (5): 1023–1030.CrossRef
31.
go back to reference Novara G, Ficarra V, Antonelli A, Artibani W, Bertini R, Carini M, et al. (2010) Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol;58(4):588-95.CrossRef Novara G, Ficarra V, Antonelli A, Artibani W, Bertini R, Carini M, et al. (2010) Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol;58(4):588-95.CrossRef
Metadata
Title
Using texture analysis as a predictive factor of subtype, grade and stage of renal cell carcinoma
Authors
Servan Yaşar
Nuray Voyvoda
Bekir Voyvoda
Tülay Özer
Publication date
01-11-2020
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02495-6

Other articles of this Issue 11/2020

Abdominal Radiology 11/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.